Tumor-associated antigen, antibodies, compositions and uses therefor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 5, 1993
Issued Date -
N/A
app pub date -
Aug 31, 1992
filing date -
Oct 20, 1989
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A novel tumor-associated antigen expressed by lung adenocarcinoma is disclosed. The antigen, characterized by monoclonal antibody LA20207, has a molecular weight in the range of about 50,000 to about 80,000 daltons and an isoelectric point in the range of about 4.9 to about 6.5. Antibodies directed against the antigen, methods for their production and diagnostic and therapeutic uses therefor are also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully